Barrett Esophagus
0
Pipeline Programs
5
Companies
6
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
PAVmedNY - New York
4 programsEsoCheckN/A1 trial
EsoGuardN/A1 trial
EsoGuardN/A1 trial
EsoGuardN/A1 trial
Active Trials
+1 more trials
Knight TherapeuticsQC - Montréal
1 programCytology Specimen Collection ProcedureN/A1 trial
Active Trials
AstraZenecaCAMBRIDGE, United Kingdom
1 programMethylene Blue Chromoendoscopy in Barrett's EsophagusN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
PAVmedEsoCheck
PAVmedEsoGuard
PAVmedEsoGuard
PAVmedEsoGuard
Knight TherapeuticsCytology Specimen Collection Procedure
AstraZenecaMethylene Blue Chromoendoscopy in Barrett's Esophagus
Clinical Trials (6)
Total enrollment: 111 patients across 6 trials
N/AUnknown
CLUE: CLinical Utility Study of EsoGuard
Start: Feb 2023Est. completion: Dec 2024
N/ACompleted
Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC
Start: Jun 2020Est. completion: Dec 2023
N/AUnknown
Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE
Start: Feb 2020Est. completion: Aug 2022
N/ACompleted
Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease
Start: Aug 2016Est. completion: Oct 201711 patients
N/ACompleted
Methylene Blue Chromoendoscopy in Barrett's Esophagus
Start: Dec 2002Est. completion: Dec 2009100 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
5 companies competing in this space